Milkie Vu1, Carla J Berg2, Cam Escoffery3, Hyun M Jang4, Tien T Nguyen5, Lisa Travis6, Robert A Bednarczyk7. 1. Department of Behavioral, Social, and Health Education Sciences, Rollins School of Public Health, Emory University, Atlanta, GA, United States. Electronic address: milkie.vu@emory.edu. 2. Department of Prevention and Community Health, Milken Institute School of Public Health, George Washington University, Washington, DC, United States; George Washington Cancer Center, George Washington University, Washington, DC, United States. 3. Department of Behavioral, Social, and Health Education Sciences, Rollins School of Public Health, Emory University, Atlanta, GA, United States; Winship Cancer Institute, Emory University, Atlanta, GA, United States. 4. Emory College of Arts & Science, Emory University, Atlanta, GA, United States. 5. Hanoi-Amsterdam High School for the Gifted, Hanoi, Viet Nam. 6. Woodruff Health Sciences Center Library, Emory University, Atlanta, GA, United States. 7. Winship Cancer Institute, Emory University, Atlanta, GA, United States; Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA United States.
Abstract
INTRODUCTION: Asian-Americans have been documented to have low human papillomavirus (HPV) vaccine initiation and completion. No research has attempted to examine underlying mechanisms of HPV vaccine uptake disparities among Asian-Americans. Using the P3 (practice, provider, and patient) model, this study aimed to identify practice-, provider-, and patient-level determinants of Asian-Americans' HPV vaccine intention and uptake. METHODS: We conducted a systematic review of published literature regarding practice-, provider- and patient-level determinants of vaccine intention (e.g., intention, willingness, or acceptability) and uptake (e.g., initiation or completion). Eligible studies were those presenting empirical/original data, focusing on Asian populations in the U.S., including outcomes related to HPV vaccine intention and uptake, and analyzing data on factors associated with these outcomes separately for Asian groups. RESULTS: Twenty-six studies (19 quantitative and 7 qualitative studies) were included in the review. Most commonly studied subgroups were Koreans (n = 9), Chinese (n = 6), and Cambodians (n = 5). Studies showed varied prevalence across subgroups (intention: 23.4%-72%; initiation: 14%-67%; completion: 9%-63%). Only 3 studies included measurements of practice-level determinants (language services, insurance policy). Twelve studies measured provider-level determinants (most commonly documented: HPV vaccine recommendation). All studies measured patient-level determinants (most commonly documented: HPV and HPV vaccine knowledge, perceived safety, perceived susceptibility, and perceived relationship between HPV vaccine and sexual activity). CONCLUSIONS: Existing research on determinants of HPV vaccine intention and uptake among Asian-Americans currently lacks measurements of practice-level constructs and perspectives of clinic staff and providers, which are needed to guide system-level interventions and provider training. Data regarding patient-level determinants suggest that interventions for Asian-American populations can focus on providing educational information in culturally-appropriate manners, leveraging familial influences, and attending to access-related or cultural beliefs about HPV vaccine. Interventions should take into account varied vaccine intention and uptake prevalence in different Asian subgroups.
INTRODUCTION: Asian-Americans have been documented to have low human papillomavirus (HPV) vaccine initiation and completion. No research has attempted to examine underlying mechanisms of HPV vaccine uptake disparities among Asian-Americans. Using the P3 (practice, provider, and patient) model, this study aimed to identify practice-, provider-, and patient-level determinants of Asian-Americans' HPV vaccine intention and uptake. METHODS: We conducted a systematic review of published literature regarding practice-, provider- and patient-level determinants of vaccine intention (e.g., intention, willingness, or acceptability) and uptake (e.g., initiation or completion). Eligible studies were those presenting empirical/original data, focusing on Asian populations in the U.S., including outcomes related to HPV vaccine intention and uptake, and analyzing data on factors associated with these outcomes separately for Asian groups. RESULTS: Twenty-six studies (19 quantitative and 7 qualitative studies) were included in the review. Most commonly studied subgroups were Koreans (n = 9), Chinese (n = 6), and Cambodians (n = 5). Studies showed varied prevalence across subgroups (intention: 23.4%-72%; initiation: 14%-67%; completion: 9%-63%). Only 3 studies included measurements of practice-level determinants (language services, insurance policy). Twelve studies measured provider-level determinants (most commonly documented: HPV vaccine recommendation). All studies measured patient-level determinants (most commonly documented: HPV and HPV vaccine knowledge, perceived safety, perceived susceptibility, and perceived relationship between HPV vaccine and sexual activity). CONCLUSIONS: Existing research on determinants of HPV vaccine intention and uptake among Asian-Americans currently lacks measurements of practice-level constructs and perspectives of clinic staff and providers, which are needed to guide system-level interventions and provider training. Data regarding patient-level determinants suggest that interventions for Asian-American populations can focus on providing educational information in culturally-appropriate manners, leveraging familial influences, and attending to access-related or cultural beliefs about HPV vaccine. Interventions should take into account varied vaccine intention and uptake prevalence in different Asian subgroups.
Authors: Kayoll V Galbraith; Julia Lechuga; Coretta M Jenerette; Ltc Angelo D Moore; Mary H Palmer; Jill B Hamilton Journal: Soc Sci Med Date: 2016-04-30 Impact factor: 4.634
Authors: Margaux C Genoff; Alexandra Zaballa; Francesca Gany; Javier Gonzalez; Julia Ramirez; Sarah T Jewell; Lisa C Diamond Journal: J Gen Intern Med Date: 2016-01-19 Impact factor: 5.128
Authors: Minjin Kim; Haeok Lee; Peter Kiang; Teri Aronowitz; Lisa Kennedy Sheldon; Ling Shi; Sun Kim; Jeroan Allison Journal: J Community Health Date: 2019-08
Authors: May Rose Isnec Dela Cruz; Kathryn L Braun; Jo Ann Umilani Tsark; Cheryl Lynn Albright; John J Chen Journal: Ethn Health Date: 2018-05-10 Impact factor: 2.772
Authors: Mallory K Ellingson; Robert A Bednarczyk; Sean T O'Leary; Jason L Schwartz; Eugene D Shapiro; Linda M Niccolai Journal: J Behav Med Date: 2022-02-22
Authors: Van M Ta Park; Marcelle Dougan; Oanh L Meyer; Bora Nam; Marian Tzuang; Linda G Park; Quyen Vuong; Janice Y Tsoh Journal: Prev Med Rep Date: 2021-07-09
Authors: Jennifer Tsui; Bibiana Martinez; Michelle B Shin; Alec Allee-Munoz; Ivonne Rodriguez; Jazmin Navarro; Kim R Thomas-Barrios; W Martin Kast; Lourdes Baezconde-Garbanati Journal: J Behav Med Date: 2022-02-02